{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9297337",
  "DateCompleted": {
    "Year": "1997",
    "Month": "09",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "rus"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0507-4088",
      "JournalIssue": {
        "Volume": "42",
        "Issue": "3",
        "PubDate": {
          "Year": "1997",
          "Season": "May-Jun"
        }
      },
      "Title": "Voprosy virusologii",
      "ISOAbbreviation": "Vopr Virusol"
    },
    "ArticleTitle": "[Approaches to selecting a strain of hantavirus for developing an inactivated brain vaccine].",
    "Pagination": {
      "StartPage": "105",
      "EndPage": "108",
      "MedlinePgn": "105-8"
    },
    "Abstract": {
      "AbstractText": [
        "Four strains isolated from patients with hemorrhagic fever with the renal syndrome and from field mice, natural hosts of Hantavirus, were examined in order to choose a functionally active strain fit for the development of inactivated Hantavirus brain vaccine. Virulent strain PM-10508/89 isolated from mouse lungs was chosen. The strain was highly virulent for newborn mice and rats: 100% of infected mice aged up to 24 h and 75% of rats developed an acute lethal infection upon challenge. The incubation period of Hantavirus adapted to mouse brain was decreased from 19 to 7 days. The infective titer of the virus in brain suspension was 0.1 to 6.5 lg LD50/ml. The strain was highly immunogenic and possessed a high hemagglutinating activity."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Astakhova",
        "ForeName": "T I",
        "Initials": "TI"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Slonova",
        "ForeName": "R A",
        "Initials": "RA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kompanets",
        "ForeName": "G G",
        "Initials": "GG"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Podkhody k vyboru shtamma virusa khantaan dlia razrabotki inaktivirovanno\u012d mozgovo\u012d vaktsiny."
  },
  "MedlineJournalInfo": {
    "Country": "Russia (Federation)",
    "MedlineTA": "Vopr Virusol",
    "NlmUniqueID": "0417337",
    "ISSNLinking": "0507-4088"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vaccines, Inactivated"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Brain"
    },
    {
      "QualifierName": [
        "immunology",
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Orthohantavirus"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Hantavirus Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hemagglutination, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccines, Inactivated"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virulence"
    }
  ]
}